Case Study: Regulatory Intelligence Services to Support New Medical Device Registration in ROW Countries
Background – Client Needs:
An EU medical device manufacturer was looking to expand its market beyond Europe for a new medical device (Class IIb). The manufacturer was looking for Regulatory Intelligence for 48+ countries to market this new product leveraging their CE mark approval in the EU.
The client faced the following challenges:
The scope of Celegence activities was to provide advisory consulting through a comprehensive Regulatory Intelligence (RI) report covering registration requirements for 48 Rest of the World (ROW) markets related to a Class IIB (EU) Medical Device. This report would be used by the client to define their global regulatory submission and product launch strategy. The Celegence team would also monitor changes to the global as well as local country requirements and provide updated Regulatory Intelligence report on an ongoing basis to ensure up-to-date information.
Project Initiation & Key Objectives:
The client chose to leverage Celegence’s team of regulatory experts to support this regulatory intelligence project based on our extensive expert network and ability to maintain the report in a cost-efficient manner.
The client’s objectives involved realising the following business benefits via their outsourcing strategy:
Celegence Solution & Approach:
Celegence was awarded a contract to provide Regulatory Intelligence services detailing information required for obtaining registration certificate in 48 countries, including:
The initial research was done by the offshore Celegence team by using secondary research methods. The information was gathered using public regulatory sources for each market including the following:
For countries or regions where the data was not accessible from initial research, the following approach was taken:
The output of the research and analysis was a comprehensive Regulatory Intelligence report with the required information for registration, including local classification, clinical trial requirements, import/export requirements, and local representative requirements. The report also included detailed steps for registering the device leveraging the CE mark and hence finding accelerated registration pathways.
Key to the success of the project was our team’s integration of local experts, in house medical device experts, and direct contact with health authorities to create a comprehensive report. In addition, most of the regulations, guidance documents and information were only available in local languages, so our multilingual technical experts helped to assess the information in English.
Key Project Achievements
Celegence delivered the following value and business impact to the client:
The information obtained in the report will be incorporated in Celegence’s Regulatory Intelligence technology platform, SRI (Simplified Regulatory Intelligence), which will be launched in Q4 2019. SRI will provide clients with the required inputs for defining their regulatory submission strategy, along with the capability to share information related to various process areas such as quality, labeling, and pharmacovigilance. This collaborative and innovative technology platform will also allow our clients to gather and maintain knowledge obtained during the registration process, interact with local subject matter experts, and receive ongoing updates about local country requirements from the Celegence team.